NCT01034358View on ClinicalTrials.gov

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Inflammatory Bowel DiseaseUterine Cervical Dysplasia
Interventions
BIOLOGICAL

Human Papillomavirus Vaccine

0.5mL intramuscular for 3 doses at 0, 2, and 6 months

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Mayo Clinic

OTHER